Application of Modified Polyether Sulfone Microspheres in Hyperbilirubinemia
Abstract
To design and prepare a high efficiency bilirubin adsorbent with good mechanical properties and biocompatibility.
Methods In this study, quaternary ammonium pyridine was designed and synthesized, and then modified polyether sulfone microspheres, or PES/p(4-VP-co-N-VP)@6 microspheres, were prepared by phase conversion and electrostatic spraying. The morphology of the polymer components and the microspheres were studied by means of nuclear magnetic resonance (NMR) spectroscopy and scanning electron microscopy. The basic properties of the microspheres and their bilirubin adsorption efficiency were tested, and the adsorption mechanism was further explored. Blood cell counts and the clotting time of the microspheres were also measured.
Results The diameter of the modified polyether sulfone microspheres prepared in the study was approximately 700-800 μm. Compared with the original PES microspheres, the surface and internal structure of PES/p(4-VP-co-N-VP)@6 microspheres did not change significantly, and they also had a loose porous structure, with some micropores scattered around in addition to irregular large pores. Compared with the control group, the bilirubin removal effect of the modified microspheres was (94.91±0.73)% after static adsorption in bilirubin PBS buffer solution for 180 min, with the difference being statistically significant (P<0.0001). According to the findings for the clotting time, the activated partial thromboplastin time (APTT) of the blank plasma group, the control PES group, and the modified PES microsphere group were (27.57±1.25) s, (28.47±0.45) s, and (30.4±0.872) s, respectively, and the difference between the experimental group and the other two groups was statistically significant (P<0.01, P<0.05). There was no significant change in red blood cell and white blood cell counts.
Conclusion The microspheres prepared in the study have high efficiency in bilirubin adsorption, excellent mechanical properties and thermal stability, and good blood biocompatibility, and are expected to be used in the clinical treatment of patients with liver failure.
Keywords: Hyperbilirubinemia, Pyridine quaternary ammonium salt, Modified polyether sulfone microspheres, Bilirubin adsorbent, Hemoperfusion
Full Text:
PDFReferences
TRIPATHI N, JIALAL I. Conjugated Hyperbilirubinemia. StatPearls Publishing, Treasure Island (FL), 2023. http://europepmc.org/abstract/MED/32965843.
HUANG S, ZHENG J, ZHANG Y, et al. Polydopamine decorated ordered mesoporous carbon for efficient removal of bilirubin under albumin-rich conditions. J Mater Chem B, 2020, 8(2): 290–297. doi: 10.1039/C9TB02147G.
CHEN J, CHENG G, CHAI Y, et al. Preparation of nano-CaCO3/polystyrene nanocomposite beads for efficient bilirubin removal. Colloids Surf B Biointerfaces, 2018, 161: 480–487. doi: 10.1016/j.colsurfb. 2017.11.017.
FUJIWARA R, HAAG M, SCHAEFFELER E, et al. Systemic regulation of bilirubin homeostasis: Potential benefits of hyperbilirubinemia. Hepatology, 2018, 67(4): 1609–1619. doi: 10.1002/hep.29599.
LAI K, SONG X L, SHI H S, et al. Bilirubin enhances the activity of ASIC channels to exacerbate neurotoxicity in neonatal hyperbilirubinemia in mice. Sci Transl Med, 2020, 12(530): eaax1337. doi: 10.1126/scitranslmed. aax1337.
SONG X, XU T, YANG L, et al. Self-anticoagulant nanocomposite spheres for the removal of bilirubin from whole blood: a step toward a wearable artificial liver. Biomacromolecules, 2020, 21(5): 1762–1775. doi: 10.1021/acs.biomac.9b01686.
SONG X, HUANG X, LI Z, et al. Construction of blood compatible chitin/graphene oxide composite aerogel beads for the adsorption of bilirubin. Carbohydr Polym, 2019, 207: 704–712. doi: 10.1016/j.carbpol. 2018.12.005.
YIN S, XU Y, WANG Z, et al. Molecularly-imprinted hydrogel beads via self-sacrificing micro-reactors as safe and selective bilirubin adsorbents. J Mater Chem B, 2022, 10(14): 2534–2543. doi: 10.1039/D1TB01895G.
JUAN Z, KAIXUAN F, PINGPING W, et al. Enhancement of the adsorption of bilirubin on activated carbon via modification. Results in Materials, 2021, 9: 100172. doi: 10.1016/j.rinma.2021.100172.
CHAI Y, LIU Z, DU Y, et al. Hydroxyapatite reinforced inorganic-organic hybrid nanocomposite as high-performance adsorbents for bilirubin removal in vitro and in pig models. Bioact Mater, 2021, 6(12): 4772–4785. doi: 10.1016/j.bioactmat.2021.05.017.
WU K, LIU X, LI Z, et al. Fabrication of chitosan/graphene oxide composite aerogel microspheres with high bilirubin removal performance. Mater Sci Eng C Mater Biol Appl, 2020, 106: 110162. doi: 10.1016/j.msec.2019.110162.
JUAN Z, YONGKE Z, YAPING Z, et al. Influence of the acid groups on activated carbon on the adsorption of bilirubin. Mater Chem Phys, 2021, 260: 124133. doi: 10.1016/j.matchemphys.2020.124133.
LI Q, YANG J, CAI N, et al. Hemocompatible hemoadsorbent for effective removal of protein-bound toxin in serum. J Colloid Interface Sci, 2019, 555: 145–156. doi: 10.1016/j.jcis.2019.07.045.
PENG Y, FENG X, JIANG J, et al. Controllable polyvinylpyrrolidone modified Polystyrene divinylbenzene for efficient adsorption of bilirubin and improvement of hemocompatibility. Euro Polymer J, 2022, 170: 111172. doi: 10.1016/j.eurpolymj.2022.111172.
WU K, YANG W, JIAO Y, et al. A surface molecularly imprinted electrospun polyethersulfone (PES) fiber mat for selective removal of bilirubin. J Mater Chem B, 2017, 5(29): 5763–5773. doi: 10.1039/C7TB00643H.
GUO X, WU F, GUO W, et al. Comparison of plasma exchange, double plasma molecular adsorption system, and their combination in treating acute-on-chronic liver failure. J Int Med Res, 2020, 48(6): 300060 520932053. doi: 10.1177/0300060520932053.
GUO L, ZHANG L, ZHANG J, et al. Hollow mesoporous carbon spheres--an excellent bilirubin adsorbent. Chem Commun (Camb), 2009, 40: 6071–6073. doi: 10.1039/B911083F.
TYAGI A, NG Y W, TAMTAJI M, et al. Elimination of Uremic Toxins by Functionalized Graphene-Based Composite Beads for Direct Hemoperfusion. ACS Appl Mater Interfaces, 2021, 13(5): 5955–5965. doi: 10.1021/acsami.0c19536.
OSMAN B, SAGDILEK E, GÜMRÜKÇÜ M, et al. Molecularly imprinted composite cryogel for extracorporeal removal of uric acid. Colloids Surf B Biointerfaces, 2019, 183: 110456. doi: 10.1016/j.colsurfb.2019.110456.
GIL H W, KIM S J, YANG J O, et al. Clinical outcome of hemoperfusion in poisoned patients. Blood Purif, 2010, 30(2): 84–88. doi: 10.1159/ 000318585.
GAN N, PENG X, WU D, et al. Effects of microsize on the biocompatibility of UiO67 from protein-adsorption behavior, hemocompatibility, and histological toxicity. J Hazard Mater, 2022, 435: 129042. doi: 10.1016/j.jhazmat.2022.129042.
Refbacks
- There are currently no refbacks.